Overview
The District Medical Officer (DMO) L.T. Saritha Kumari announced that 12,467 girls aged 14 in Kozhikode district have received the HPV vaccine. The drive, part of a state‑level special campaign, will run until 31 August 2026. The aim is to immunise all eligible girls before the deadline.
Key Developments
- 12,467 girls (14 years) vaccinated in Kozhikode.
- 1,307 vaccinations delivered through school‑based drives.
- Free administration of the vaccine that costs ₹4,000 in the private market.
- Campaign continues till 31 August 2026, urging rapid uptake.
Important Facts
Cervical cancer is caused by HPV. The vaccine stimulates the body to produce antibodies that neutralise the virus, thereby lowering the chance of cancer. In India, cervical cancer ranks second among women’s cancers, making prevention a public‑health priority.
The state government is offering the vaccine ahead of its inclusion in the National Immunisation Schedule. This first‑phase rollout targets 14‑year‑old girls, the age group most vulnerable to infection before sexual debut.
Alongside vaccination, the press release emphasised the role of cervical screening in early detection and treatment.
Exam Relevance
Health is a recurring theme in GS 1 (Society) and GS 2 (Polity) papers. Understanding the structure of public‑health administration (DMO), vaccine policy, and disease burden helps answer questions on health governance, preventive health, and programme implementation. The case illustrates federal‑state coordination, budget allocation for free vaccines, and the role of school‑based health interventions.
Way Forward
- Accelerate school‑based drives to reach the remaining eligible girls before 31 August 2026.
- Integrate the HPV vaccine into the permanent National Immunisation Schedule after the pilot phase.
- Strengthen awareness campaigns on the importance of cervical screening alongside vaccination.
- Monitor vaccine coverage data regularly to assess impact on cervical‑cancer incidence.